Amid India's request to lift ban, US defends restrictions on export of Covid vaccine raw materials Ruchika Sharma25 April 2021 9:00 AM ISTWashington: Defending U.S.' restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India's...
US CDC recommends resuming Johnson & Johnson COVID-19 vaccine Ruchika Sharma24 April 2021 6:33 PM ISTWashington: Centers for Disease Control and Prevention (CDC) vaccine advisory committee on Friday (local time) recommended resuming the use of Johnson...
USFDA flags problems at factory making Johnson and Johnson COVID vaccine Ruchika Sharma24 April 2021 12:00 PM ISTNew Delhi: The Baltimore factory hired to help make Johnson & Johnson's Covid-19 vaccine was dirty, didn't follow proper manufacturing procedures...
Serum Institute of India has not contracted all its production of COVID vaccine to Centre till May 25: Govt Medical Dialogues Bureau24 April 2021 9:15 AM ISTNew Delhi: There have been some media reports suggesting that Serum Institute of India (SII) has contracted all its production till 25th May 2021 to...
Cadila Healthcare eyes doubling Covid-19 vaccine capacity amid record India surge: Bloomberg Ruchika Sharma23 April 2021 3:38 PM ISTNew Delhi: Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp...
Pfizer, Moderna to get COVID vaccine ingredient from VAV Lifesciences Ruchika Sharma23 April 2021 2:01 PM ISTPhospholipids are crucial biomolecules used in manufacturing of mRNA-based Covid-19 vaccines.
Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid Ruchika Sharma22 April 2021 11:30 AM ISTHyderabad: Drugmaker, Bharat Biotech, has recently announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based...
PIL seeking to restrain Serum Institute from using Covishield trademark rejected Ruchika Sharma21 April 2021 12:06 PM ISTMumbai: The Bombay High Court on Tuesday refused to restrain Serum Institute of India Private Limited from using the name 'Covishield' for its vaccine...
Customs duty on imported Covid-19 vaccines likely to be waived by 10 percent Ruchika Sharma21 April 2021 11:26 AM ISTNew Delhi: The government is likely to waive 10 percent customs duty levied on imported vaccines in a bid to keep low the cost of overseas vaccines...
Bharat Biotech to expand Covaxin production capacity to 700 million doses annually Ruchika Sharma21 April 2021 10:30 AM ISTHyderabad: Bharat Biotech recently announced that it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per...
Johnson and Johnson seeks CDSCO nod for phase 3 trial of single-dose COVID vaccine Ruchika Sharma20 April 2021 11:00 AM ISTThe Johnson and Johnson vaccine can be stored for up to three months in a temperature between 2 and 8 degrees Celsius.
Serum Institute, Bharat Biotech to get Rs 45.67 billion to boost Covid-19 vaccine production capacity Ruchika Sharma20 April 2021 10:30 AM ISTNew Delhi: India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and...
